Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fluctuation of physical function during chimeric antigen receptor T-cell therapy during rehabilitation intervention: Real-world data and risk factor analyses.
Hamada R, Arai Y, Kitawaki T, Nakamura N, Murao M, Matsushita M, Miyasaka J, Asano T, Jo T, Nishikori M, Kanda J, Mizumoto C, Yamashita K, Ikeguchi R, Takaori-Kondo A. Hamada R, et al. Among authors: jo t. EJHaem. 2024 Nov 4;5(6):1252-1259. doi: 10.1002/jha2.1043. eCollection 2024 Dec. EJHaem. 2024. PMID: 39691237 Free PMC article.
[Clinical experience of leukapheresis for CD19 CAR-T cell therapy].
Jo T, Yoshihara S, Arai Y, Ikemoto J, Onomoto H, Sugiyama H, Yoshihara K, Matsui K, Niwa N, Nakagawa Y, Kitawaki T, Kanda J, Takaori-Kondo A, Nagao M. Jo T, et al. Rinsho Ketsueki. 2021;62(3):163-169. doi: 10.11406/rinketsu.62.163. Rinsho Ketsueki. 2021. PMID: 33828008 Japanese.
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy.
Jo T, Yoshihara S, Hada A, Arai Y, Kitawaki T, Ikemoto J, Onomoto H, Sugiyama H, Yoshihara K, Obi N, Matsui K, Niwa N, Nakagawa Y, Kanda J, Kondo T, Saida S, Kato I, Hiramatsu H, Adachi S, Takita J, Takaori-Kondo A, Nagao M. Jo T, et al. Transplant Cell Ther. 2022 Jul;28(7):365.e1-365.e7. doi: 10.1016/j.jtct.2022.04.013. Epub 2022 Apr 20. Transplant Cell Ther. 2022. PMID: 35460928 Free article.
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma.
Yamasaki-Morita M, Arai Y, Ishihara T, Onishi T, Shimo H, Nakanishi K, Nishiyama Y, Jo T, Hiramatsu H, Mitsuyoshi T, Mizumoto C, Kanda J, Nishikori M, Kitawaki T, Nogami K, Takaori-Kondo A, Nagao M, Adachi S. Yamasaki-Morita M, et al. Among authors: jo t. Blood Adv. 2022 Jul 26;6(14):4216-4223. doi: 10.1182/bloodadvances.2022007454. Blood Adv. 2022. PMID: 35580321 Free PMC article.
Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T-cell therapy.
Nakamura N, Arai Y, Kitawaki T, Jo T, Mizumoto C, Kanda J, Nishikori M, Yamashita K, Takaori-Kondo A. Nakamura N, et al. Among authors: jo t. Br J Haematol. 2023 Jan;200(1):e1-e3. doi: 10.1111/bjh.18504. Epub 2022 Oct 11. Br J Haematol. 2023. PMID: 36220156 Free PMC article. No abstract available.
[CAR T-cell therapy for malignant lymphoma].
Jo T, Arai Y. Jo T, et al. Rinsho Ketsueki. 2024;65(6):536-546. doi: 10.11406/rinketsu.65.536. Rinsho Ketsueki. 2024. PMID: 38960654 Japanese.
544 results